1. Corporate Officers - A
2. Ahrens Brenton Karl

Insider Trading History of Ahrens Brenton Karl

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ahrens Brenton Karl since 2012. This trader's CIK number is 1322927. At the time of last reporting, Ahrens Brenton Karl was the Director of Iterum Therapeutics Plc. (stock ticker symbol ITRM). Also see all insider trading activities at Iterum Therapeutics Plc.

Note that in the past Ahrens Brenton Karl also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Iterum Therapeutics Plc (ITRM) by Ahrens Brenton Karl

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	ITRM	0	$0	115,544	$238,567	0	$0
2019	ITRM	0	$0	0	$0	6,154	$0
2018	ITRM	506,656	$6,586,528	0	$0	0	$0

Yearly summary of insider trading at Durata Therapeutics, Inc. (DRTX) by Ahrens Brenton Karl

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2014	DRTX	0	$0	0	$0	5,034	$10,470
2012	DRTX	555,555	$4,999,995	0	$0	0	$0

Insider trading activities at 2 companies by Ahrens Brenton Karl:

1. Iterum Therapeutics Plc (ITRM)

2. Durata Therapeutics, Inc. (DRTX)

Table 1. Insider trading of Iterum Therapeutics Plc (ITRM) by Ahrens Brenton Karl

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-09-19	ITRM	Sale	15,000	1.76	26,475
2022-09-20	ITRM	Sale	7,246	1.78	12,912
2022-09-16	ITRM	Sale	15,000	1.90	28,545
2022-09-13	ITRM	Sale	15,000	2.14	32,115
2022-09-14	ITRM	Sale	15,000	2.10	31,455
2022-09-15	ITRM	Sale	15,000	2.02	30,269
2022-09-08	ITRM	Sale	3,298	2.26	7,466
2022-09-09	ITRM	Sale	15,000	2.31	34,725
2022-09-12	ITRM	Sale	15,000	2.31	34,605
2019-05-24	ITRM	Option Ex	6,154	.00	0
2018-05-30	ITRM	Buy	506,656	13.00	6,586,528

Table 2. Insider trading of Durata Therapeutics, Inc. (DRTX) by Ahrens Brenton Karl

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2014-08-26	DRTX	Option Ex	5,034	2.08	10,470
2012-07-24	DRTX	Buy	555,555	9.00	4,999,995

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ahrens Brenton Karl (Director of Iterum Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month